© Globe Newswire
05.01.2026
NMRA
LISTED
NASDAQ
Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones
News Preview
Multiple clinical data readouts expected in 2026 present opportunity for substantial value creation...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
NUTX
LISTED
NASDAQ
NUTEX HEALTH TO ATTEND AND PRESENT AT THE 2026 J.P. MORGAN HEALTHCARE CONFERENCE IN JANUARY IN SAN FRANCISCO
News Preview
HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 26 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that the Compan...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
NMRA
LISTED
NASDAQ
Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer’s Disease Agitation
News Preview
NMRA-511 demonstrated a 15.7 reduction on mean CMAI total score, representing a clinically meaningful effect ...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© ACCESS Newswire
05.01.2026
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC Pink: MDCE) Announces Completion of Readiness Testing for AI-Powered Skin Lesion Pre-Screening Mobile Application
News Preview
MESA, ARIZONA / ACCESS Newswire / January 5, 2026 / Medical Care Technologies Inc. (OTC Pink:MDCE) announced today that the Company has successfully completed its internal readiness testing phase for its forthcoming AI-powered mobile application designed for skin lesion pre-screening and risk-awareness. The mobile application is scheduled for publi...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
05.01.2026
1696
LISTED
HKSE
Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China
News Preview
Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics PortfolioHONG KONG, Jan. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global wellness group offering Energy-Based Devices (EBD), injectables, diagon...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
1696
LISTED
HKSE
Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China
News Preview
Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics PortfolioHONG KONG, Jan. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global wellness group offering Energy-Based Devices (EBD), injectables, diagon...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
1J5
LISTED
SES
Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European countries
News Preview
Cerapro® is a patented, skin pH-lowering cream approved for the treatment of atopic dermatitis under the European Medical Device Regulation (CE Mark)Product launch targeted for 2026 in six European markets, including Switzerland, Austria, the Netherlands and Belgium. SINGAPORE, Jan. 5, 2026 /PRNewswire/ -- Hyphens Pharma International Limited ("H...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
1J5
LISTED
SES
Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European countries
News Preview
Cerapro® is a patented, skin pH-lowering cream approved for the treatment of atopic dermatitis under the European Medical Device Regulation (CE Mark)Product launch targeted for 2026 in six European markets, including Switzerland, Austria, the Netherlands and Belgium. SINGAPORE, Jan. 5, 2026 /PRNewswire/ -- Hyphens Pharma International Limited ("H...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
PRPH
LISTED
NASDAQ
ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value
News Preview
UNIONDALE, NY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) today provided an update to shareholders regarding recent trading activity, its capital structure, and the Company’s underlying asset base....
Themefolio
Profiler
Peergroup
© ACCESS Newswire
05.01.2026
IGC
LISTED
XASE
IGC Pharma Raises Capital to Advance IGC-AD1 Phase 2 Trial
News Preview
- New Financing Supports Disciplined Clinical Execution and Value Creation in Alzheimer's Drug Development - POTOMAC, MARYLAND / ACCESS Newswire / January 5, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company leveraging Artificial Intelligence (AI) to develop innovative t...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
05.01.2026
TELO
LISTED
NASDAQ
Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models
News Preview
In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread. MIAMI, FLORIDA / ACCESS Newswire / January 5, 2026 / Telomir Pharmaceuticals (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology comp...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
ALTME
LISTED
EURONEXT
TME Pharma provides update on its activities
News Preview
TME Pharma provides update on its activities...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© ACCESS Newswire
05.01.2026
MRNA
LISTED
NASDAQ
Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine
News Preview
Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an update on regulatory submissions for its investigational seasonal influenza vaccine, mRNA-1010, for adults aged 50 years and older. The Company has filed...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
EQS
LISTED
EURONEXT
EQUASENS ACCELERATES ITS DIGITAL TRAINING STRATEGY FOR HEALTHCARE PROFESSIONALS WITH THE ACQUISITION OF EREVO, A LEADING PURE-PLAY E-LEARNING PROVIDER
News Preview
Acquisition of a controlling 80% stake in Erevo, which is expected to generate revenue of €7.4 million in 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
SAN
LISTED
EURONEXT
Press Release: Sanofi’s Tzield accepted for priority review in the US for young children with stage 2 type 1 diabetes
News Preview
Sanofi’s Tzield accepted for priority review in the US for young children with stage 2 type 1 diabetes...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
IDIA
LISTED
SIX
Idorsia’s JERAYGO (aprocitentan) approved in Canada for the treatment of resistant hypertension
News Preview
Allschwil, Switzerland – January 5, 2026Idorsia Ltd (SIX: IDIA) announces that Health Canada has granted marketing authorization for JERAYGO™ (aprocitentan) for the treatment of resistant hypertension in adult patients in combination with at least three antihypertensive medicinal products.1 The recommended dose is 12.5 mg orally once daily. The dos...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
13
LISTED
HKSE
HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma
News Preview
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the Phase III part of the Phase II/III trial to evaluate the efficacy of the combination of surufatinib, camrelizumab, nab-paclitaxel and gemcitabine as a first-li...
Themefolio
Profiler
Peergroup
© BusinessWire
04.01.2026
475830
LISTED
KOE
Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Drive Degrader-Antibody Conjugate Innovation and Programs
News Preview
Orum Therapeutics (Orum or the Company) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Chad May, Ph.D., as Chief Scientific Officer (CSO). Dr. May brings more than 20 years of oncology and immunology research experience with a track record of advancing antibody...
Themefolio
Profiler
Peergroup
© BusinessWire
04.01.2026
AGL
LISTED
NYSE
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“Agilon” or “the Company”) (NYSE: AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Invest...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.01.2026
CRNX
LISTED
NASDAQ
Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia
News Preview
SAN DIEGO, Jan. 04, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host a conference call and webcast on Monday, January 5, 2026 at 8:30 a.m. ET to provide an update on PALSONIFY™ (paltusotine) commercialization and disclose topline results from the fourth cohort of the Phase 2 trial...
Themefolio
Profiler
Peergroup
© BusinessWire
04.01.2026
SVA
LISTED
NASDAQ
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement
News Preview
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua High Court’s interlocutory order governing the Company’s board composition and corporate actions pending trial, and announced the engagement of Zhonghua Certified Public Accountants LLP...
Themefolio
Profiler
Peergroup
© BusinessWire
04.01.2026
SVA
LISTED
NASDAQ
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report
News Preview
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, 2026 (the “Notification Letter”) from Nasdaq Listing Qualifications (“Nasdaq”), stating that the Company was not in compliance with Nasdaq’s Listing...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
03.01.2026
NTHI
LISTED
NASDAQ
New to The Street Airs Tonight on Bloomberg Television - Show No. 712 Sponsored Programming Spotlighting Public and Private Market Innovators
News Preview
The show airs as sponsored programming and is supported by television commercial sponsors Synergy CHC (NASDAQ:SNYR) featuring its Focus Factor® Drinks, DataVault AI (NASDAQ:DVLT), HelloAxel.COM, and Sustainable Green Team (OTC: SGTM). NEW YORK CITY, NEW YORK / ACCESS Newswire / January 3, 2026 / New to The Street, the long-running business tel...
Themefolio
Profiler
Peergroup
© BusinessWire
03.01.2026
PRGO
LISTED
NYSE
PRGO: Kirby McInerney LLP Advises Perrigo Company plc Investors of Class Action Lawsuit
News Preview
Kirby McInerney LLP reminds investors who purchased Perrigo Company plc (“Perrigo” or the “Company”) (NYSE:PRGO) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
If you...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.01.2026
PLTH
LISTED
CSE
Planet 13 Announces Grant of RSU
News Preview
LAS VEGAS, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced that it has granted Restricted Stock Units (“RSUs”) to certain of its officers, directors and employees....
Themefolio
Profiler
Peergroup
© Newsfile
02.01.2026
VIVI
LISTED
CSE
TempraMed Provides Positive Recap on 2025 and Strategic Outlook for 2026
News Preview
Vancouver, British Columbia--(Newsfile Corp. - January 2, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to provide a positive recap on the year as well as a strategic outlook for the year...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
EVH
LISTED
NYSE
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08
News Preview
WASHINGTON, Jan. 2, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, announced that the Compensation Committee of Evolent's Board of Directors approve...
Themefolio
Profiler
Peergroup
© BusinessWire
02.01.2026
XERS
LISTED
NASDAQ
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on January 2, 2026, the Compensation Committee of Xeris’ Board of Directors granted restricted stock units for an aggreg...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
KPTI
LISTED
NASDAQ
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
NEWTON, Mass., Jan. 2, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 1,533 restricted stock units (RSUs) to two newly-hired employees. These RSU awards were granted as of December 31, 2025 (the "...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
ADCT
LISTED
NYSE
ADC Therapeutics Announces New Employee Inducement Grant
News Preview
LAUSANNE, Switzerland, Jan. 2, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made a grant of options to purchase an aggregate of 6,000 of the Company's common shares to a new employee on January 2, 2026 ("Gran...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.01.2026
RXST
LISTED
NASDAQ
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
News Preview
ALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference....
Themefolio
Profiler
Peergroup
© Globe Newswire
02.01.2026
TERN
LISTED
NASDAQ
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
News Preview
FOSTER CITY, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that it has granted as of January 1, 2026 equity inducement awards to two new employees under the terms of the 2022 Employment Inducement Award Plan, as amended. The equit...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.01.2026
REGN
LISTED
NASDAQ
Regeneron to Report Fourth Quarter and Full Year 2025 Financial and Operating Results and Host Conference Call and Webcast on January 30, 2026
News Preview
TARRYTOWN, N.Y., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its fourth quarter and full year 2025 financial and operating results on Friday, January 30, 2026, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.01.2026
NTLA
LISTED
NASDAQ
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CAMBRIDGE, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on January 1, 2026, it awarded inducement grants to two new employees under Intellia’s 2024 Inducement Plan as a material...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
CRSP
LISTED
NASDAQ
Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize
News Preview
Issued on behalf of Avant Technologies Inc.VANCOUVER, BC, Jan. 2, 2026 /CNW/ -- Equity Insider News Commentary – The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source[1]. The FDA approved three transformative cell therapies this December alone...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
CRSP
LISTED
NASDAQ
Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize
News Preview
Issued on behalf of Avant Technologies Inc.VANCOUVER, BC, Jan. 2, 2026 /PRNewswire/ -- Equity Insider News Commentary – The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source[1]. The FDA approved three transformative cell therapies this Decembe...
Themefolio
Profiler
Peergroup
© BusinessWire
02.01.2026
INSP
LISTED
NYSE
Deadline Soon: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming January 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusi...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.01.2026
CHE
LISTED
NYSE
Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26
News Preview
CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange....
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© BusinessWire
02.01.2026
ALGN
LISTED
NASDAQ
Align Technology to Announce Fourth Quarter and 2025 Results on February 4, 2026
News Preview
Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and full year 2025 financial res...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
HOTH
LISTED
NASDAQ
Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP Platform
News Preview
NEW YORK, Jan. 2, 2026 /PRNewswire/ -- Hoth Therapeutics (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies for underserved medical needs, today announced the filing of two U.S. provisional patent applications that significantly expand the Company's intellectual property portfolio and establish a new oncolog...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
BSX
LISTED
NYSE
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results
News Preview
MARLBOROUGH, Mass., Jan. 2, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026, in San Francisco. Mike Mahoney, chairman and chief executive officer, Jon Monson, executive vice president and chief financial officer, and Ken Stein, M.D.,...
Themefolio
Profiler
Peergroup
© Newsfile
02.01.2026
PHRM
LISTED
CSE
PharmaTher CEO Publishes Letter to Shareholders
News Preview
Toronto, Ontario--(Newsfile Corp. - January 2, 2026) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher") today announced that CEO Fabio Chianelli has published a letter to shareholders.Dear Shareholders,With 2025 complete, I want to thank you for your continued support of PharmaTher. This past year marked...
Themefolio
Profiler
Peergroup
© BusinessWire
02.01.2026
JNJ
LISTED
NYSE
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026
News Preview
Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2026 of $1.30 per share on the company’s common stock. The dividend is payable on March 10, 2026 to shareholders of record at the close of business on February 24, 2026. The ex-dividend date is February 24, 2026.
Ab...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
PCLO
LISTED
TSX
Canadian Investment Regulatory Organization Trade Resumption - PCLO
News Preview
VANCOUVER, BC, Jan. 2, 2026 /CNW/ - Trading resumes in:
Company: Pharmacielo Ltd.TSX-Venture Symbol: PCLOAll Issues: YesResumption (ET): 9:30 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the nation...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.01.2026
CDT
LISTED
NASDAQ
CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy
News Preview
CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy...
Themefolio
Profiler
Peergroup
© BusinessWire
02.01.2026
IRWD
LISTED
NASDAQ
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance
News Preview
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today announced financial guidance for full year 2026.
“Throughout 2025, we made significant progress in maximizing LINZESS while delivering sustained profit...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
INNO
LISTED
CSE
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
News Preview
HERZLIA, Israel and CALGARY, AB, Jan. 2, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, today announced that it anticipates to list on NYSE American on or around January 7,...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
INNO
LISTED
CSE
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
News Preview
HERZLIA, Israel and CALGARY, AB, Jan. 2, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, today announced that it anticipates to list on NYSE American on or around January 7,...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
INNO
LISTED
CSE
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
News Preview
HERZLIA, Israel and CALGARY, AB, Jan. 2, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, today announced that it anticipates to list on NYSE American on or around January 7, 2026, s...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
INSM
LISTED
NASDAQ
Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
BRIDGEWATER, N.J., Jan. 2, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the J.P. Morgan 2026 Healthcare Conference in San Fran...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.01.2026
GNLX
LISTED
NASDAQ
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer
News Preview
WESTLAKE VILLAGE, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Jason Litten, M.D., as Chief Medical Officer, effective January 2, 2026. Dr. Litten will oversee all clinical development and medical strategy as the company advances O...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.01.2026
LNTH
LISTED
NASDAQ
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies
News Preview
BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, today announced it has completed the previously announced sale of its single pho...
Themefolio
Profiler
Peergroup
© BusinessWire
02.01.2026
BMY
LISTED
NYSE
Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at J.P. Morgan’s 44th Annual Healthcare Conference on Monday, January 12, 2026.
The company’s presentation and participation in a fireside chat will begin at 7:30 a.m. PST/10:30 a.m. ET.
The event will be webcast simultaneously at http://investor.bms.com, with mater...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.01.2026
BBIO
LISTED
NASDAQ
BridgeBio to Host Achondroplasia Investor Webinar on Friday, January 9th at 8:00 am ET
News Preview
PALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced the Company will host an investor webinar on Friday, January 9, 2026 at 8:00 am ET with Janet Legare, M.D., Professor in the Divisions of Ge...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
HAE
LISTED
NYSE
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference
News Preview
BOSTON, Jan. 2, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 at 7:30 am Pacific Time....
Themefolio
Profiler
Peergroup
© Globe Newswire
02.01.2026
LOVE
LISTED
TSX
Cannara Achieves #1 Market Share Position in Québec as of December 2025 and Provides Update on Québec Vape Category Launch
News Preview
Cannara #1 in Québec market share(Dec 2025); Quebec vape launch leads with 29.7% share. Cancels/reissues 544,600 options....
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Total Voting Rights
News Preview
02 January 2026
LEI: 5493003YBCY4W1IMJU04
Worldwide Healthcare Trust PLC
Voting Rights and Capital
...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
02.01.2026
JAGX
LISTED
NASDAQ
Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
News Preview
SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that it received notice from the U.S. Food and Drug Administration's Center for Veterinary Medicine (CVM) on January 1, 2026 that the company has been awarded a $240,000 grant. Canalevia-CA1 is currently conditional...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
02.01.2026
AIMD
LISTED
NASDAQ
Ainos Articulates Its Platform Strategy to Digitize Smell as the Next Native AI Data Language
News Preview
A Dual-Engine SmellTech Architecture: Ainos at the Edge, ScentAI Scaling AI Intelligence HOUSTON, TX / ACCESS Newswire / January 2, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) today released a statement from Chairman, President and Chief Executive Officer Eddy Tsai, outlining the Company's long-term platform strategy to digitize smell as a nativ...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
